ctrl K

AI Score

Unlock

Akero Therapeutics Inc. (AKRO)

AI Score

Unlock

43.58

0.29 (0.67%)

At close: Mar 27, 2025, 3:59 PM

46.51

6.72%

After-hours: Mar 27, 2025, 07:59 PM EDT

Akero Therapeutics Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	29K	260K	244K	213K	n/a	n/a	n/a
Gross Profit	n/a	-29K	-260K	-244K	-213K	n/a	n/a	n/a
Operating Income	-285.42M	-172.87M	-115.16M	-100.89M	-80.15M	-45.65M	-13.78M	-4.56M
Interest Income	n/a	24.21M	3.86M	109K	947K	1.9M	n/a	n/a
Pretax Income	-252.06M	-151.76M	-112.03M	-100.78M	-79.21M	-43.76M	-81.71M	-4.56M
Net Income	-252.06M	-151.76M	-108.91M	-100.74M	-79.19M	-43.76M	-81.71M	-4.56M
Selling & General & Admin	37.93M	31.07M	29.87M	19.13M	15.24M	8.61M	1.9M	1.08M
Research & Development	247.5M	141.8M	85.28M	81.76M	64.92M	37.05M	11.88M	3.49M
Other Expenses	n/a	n/a	3.86M	109K	947K	1.9M	-67.94M	n/a
Operating Expenses	285.42M	172.87M	115.16M	100.89M	80.15M	45.65M	13.78M	4.56M
Interest Expense	-4.67M	3.1M	739K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-98K
Cost & Expenses	n/a	172.87M	115.16M	100.89M	80.15M	45.65M	13.78M	4.56M
Income Tax	n/a	n/a	-3.12M	-41K	-17K	24K	-68.1M	-4.98M
Shares Outstanding (Basic)	67.14M	52.57M	38.98M	34.83M	31.46M	15.07M	21.22M	28.56M
Shares Outstanding (Diluted)	67.14M	52.57M	38.98M	34.83M	31.46M	15.07M	21.22M	28.56M
EPS (Basic)	-3.75	-2.89	-2.79	-2.89	-2.52	-2.9	-3.85	-0.16
EPS (Diluted)	-3.75	-2.89	-2.79	-2.89	-2.52	-2.9	-3.85	-0.16
EBITDA	-285.42M	-148.63M	-111.03M	-100.53M	-78.99M	-45.65M	-68.46M	-232.36K
Depreciation & Amortization	n/a	29K	260K	244K	213K	-104K	13.78M	4.98M